Protein synthesis substrate supply

"Protein synthesis substrate supply" describes the availability of amino acids, the essential building blocks required for protein biosynthesis in cells. This process occurs via transcription of DNA to mRNA in the nucleus (eukaryotes) followed by translation at ribosomes in the cytoplasm, where amino acids are assembled into polypeptide chains.[1][3][5][6] Amino acids serve dual roles as substrates for peptide bond formation and signaling molecules (e.g., leucine activating mTOR via PI3K-Akt pathways to regulate synthesis rates).[2][4] Inadequate or asynchronous supply, as shown in myotube studies, reduces protein accumulation by downregulating factors like IRS1, EGFR, and p-Akt, leading to increased degradation.[2] It is not a specific therapeutic target like an enzyme or receptor but a nutritional and metabolic concept critical for cell growth, repair, and response to stress. Dysregulation links indirectly to diseases like cachexia or sarcopenia through impaired muscle protein balance, though interventions focus on nutrition or downstream pathways rather than this supply mechanism itself.[2][6] No approved drugs directly interact with it; research emphasizes precise amino acid delivery for optimizing synthesis in biotechnology or animal nutrition.[2][4]